To further explore the prognostic value of RIPK4 in tumors, we performed pan-cancer assays and observed that RIPK4 expression was associated with KIRP, KIRC, PAAD, COAD, and ACC. This evidence concerns the gene RIPK4 and colon adenocarcinoma.